What is the market doing?
What the tape says about DNLI
Denali Therapeutics Inc. is +73% over the past year while the S&P 500 is +23%: 50 points ahead of the market.
+73%
1-year return · S&P 500 +23%
- vs 200-day average
- +23%
vs 200-day average · a clear uptrend
- RSI (14)
- 49
RSI (14) · neutral
- Below its 52-week high
- −7.2%
Below its 52-week high
Details›
- Last close2026-08-26
- $24.58
- 1 monthS&P 500 +3.7%
- +5.0%
- 1 yearS&P 500 +23%
- +73%
- 5 yearsS&P 500 +87%
- −51%
- vs 50-day average$23.30
- +5.5%
- 52-week high
- $26.48
- 52-week low
- $12.75
- Annualised volatility
- 60%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$865K
| Year | Return |
|---|---|
| 2026 (year to date) | +49% |
| 2025 | −19% |
| 2024 | −5.0% |
| 2023 | −23% |
| 2022 | −38% |
| 2021 | −47% |
| 2020 | +381% |
| 2019 | −16% |
| 2018 | +32% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 5 of 9 | +6.9% |
| Feb | 9 | 3 of 9 | −2.3% |
| Mar | 9 | 2 of 9 | −8.8% |
| Apr | 9 | 5 of 9 | +0.77% |
| May | 9 | 7 of 9 | +5.6% |
| Jun | 9 | 6 of 9 | +7.3% |
| Jul | 9 | 3 of 9 | −4.4% |
| Aug | 9 | 6 of 9 | +6.2% |
| Sep | 8 | 4 of 8 | +2.2% |
| Oct | 8 | 3 of 8 | −3.7% |
| Nov | 8 | 5 of 8 | +14% |
| Dec | 8 | 3 of 8 | +1.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.